Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-006603
Filing Date
2017-06-19
Accepted
2017-06-19 16:21:12
Documents
1
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3061517ray_actiniumphar.html 3  
1 OWNERSHIP DOCUMENT f3061517ray_actiniumphar.xml 3 3016
  Complete submission text file 0001213900-17-006603.txt   4460
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14 BAYBURY COURT EAST HANOVER NJ 07936
Business Address
Ray Nitya G. (Reporting) CIK: 0001709522 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36374 | Film No.: 17918736